

Medilink, a Chinese biotech company, has secured $50 million in Series A financing. The investors include Apricot Capital, Loyal Valley Capital and Qiming Venture Partners.
Source: Press Release
Medilink, a Chinese biotech company, has secured $50 million in Series A financing.
Medilink, a Chinese biotech company, has secured $50 million in Series A financing. The investors include Apricot Capital, Loyal Valley Capital and Qiming Venture Partners.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination